Your browser doesn't support javascript.
loading
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Abida, Wassim; Campbell, David; Patnaik, Akash; Shapiro, Jeremy D; Sautois, Brieuc; Vogelzang, Nicholas J; Voog, Eric G; Bryce, Alan H; McDermott, Ray; Ricci, Francesco; Rowe, Julie; Zhang, Jingsong; Piulats, Josep Maria; Fizazi, Karim; Merseburger, Axel S; Higano, Celestia S; Krieger, Laurence E; Ryan, Charles J; Feng, Felix Y; Simmons, Andrew D; Loehr, Andrea; Despain, Darrin; Dowson, Melanie; Green, Foad; Watkins, Simon P; Golsorkhi, Tony; Chowdhury, Simon.
Afiliação
  • Abida W; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York. abidam@mskcc.org.
  • Campbell D; Medical Oncology, Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia.
  • Patnaik A; Hematology and Oncology, University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • Shapiro JD; Medical Oncology, Cabrini Hospital, Malvern, Victoria, Australia.
  • Sautois B; CHU Sart Tilman, University of Liège, Liège, Belgium.
  • Vogelzang NJ; Medical Oncology, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, Nevada.
  • Voog EG; Medical Oncology, Clinique Victor Hugo Centre Jean Bernard, Le Mans, France.
  • Bryce AH; Hematology/Oncology, Mayo Clinic, Phoenix, Arizona.
  • McDermott R; Genito-Urinary Oncology, Adelaide and Meath Hospital (Incorporating the National Children's Hospital), Tallaght, Dublin, Ireland.
  • Ricci F; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
  • Rowe J; Division of Oncology, Department of Internal Medicine, The University of Texas Health Science Center at Houston and Memorial Hermann Cancer Center, Houston, Texas.
  • Zhang J; Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Piulats JM; Medical Oncology, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); ONCOBELL; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC); Hospitalet de Llobregat, Barcelona, Spain.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Higano CS; Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Krieger LE; Oncology, Northern Cancer Institute, St Leonards, New South Wales, Australia.
  • Ryan CJ; Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
  • Feng FY; Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Simmons AD; Translational Medicine, Clovis Oncology, Inc., Boulder, Colorado.
  • Loehr A; Translational Medicine, Clovis Oncology, Inc., Boulder, Colorado.
  • Despain D; Biostatistics, Clovis Oncology, Inc., Boulder, Colorado.
  • Dowson M; Study Operations, Clovis Oncology UK, Ltd, Cambridge, United Kingdom.
  • Green F; Translational Medicine, Clovis Oncology, Inc., Boulder, Colorado.
  • Watkins SP; Clinical Science, Clovis Oncology UK, Ltd, Cambridge, United Kingdom.
  • Golsorkhi T; Clinical Development, Clovis Oncology, Inc., Boulder, Colorado.
  • Chowdhury S; Medical Oncology, Guy's Hospital and Sarah Cannon Research Institute, London, United Kingdom.
Clin Cancer Res ; 26(11): 2487-2496, 2020 06 01.
Article em En | MEDLINE | ID: mdl-32086346
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article